Nuwellis Files Definitive Additional Proxy Materials

TL;DR

Nuwellis dropped more proxy docs, shareholders vote soon.

AI Summary

Nuwellis, Inc. filed a Definitive Additional Materials (DEFA14A) on April 6, 2026, related to proxy solicitations. The filing provides additional information for shareholders concerning matters to be voted on at a company meeting. Specific details regarding the proposals or resolutions are not included in this summary information.

Why It Matters

This filing provides shareholders with supplementary information for upcoming votes, ensuring they have all necessary details before making decisions on corporate matters.

Risk Assessment

Risk Level: low — This is a routine filing for proxy materials and does not indicate any immediate financial or operational risks.

Key Players & Entities

• Nuwellis, Inc. (company) — Filer of the DEFA14A
• 0001506492 (company) — CIK number for Nuwellis, Inc.
• 0001539497-26-001092 (filing_id) — SEC Accession Number for the filing
• 2026-04-06 (date) — Filing date of the DEFA14A

FAQ

Filing Documents

• n5708_x3-defa14a.htm (DEFA14A) — 22KB
• 0001539497-26-001092.txt ( ) — 23KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth information regarding the beneficial ownership (as defined in Rule 13d-3 of the Exchange Act) of our common stock as of March 24, 2026 by (i) each of the directors, nominees, and named executive officers, (ii) all of the directors and executive officers as a group, and (iii) to our knowledge, beneficial owners of more than 5% of our common stock. As of March 24, 2026, there were 2,460,477 shares of our common stock outstanding. Unless otherwise indicated and subject to applicable community property laws, each owner has sole voting and investment powers with respect to the securities listed below. Name of Beneficial Owner Number of Shares Right to Acquire (1) Total Percent of Class (2) John L. Erb 26,191 15,788 41,979 1.7% Martin Emerson - - - - Katharyn Field (3) - - - - Archelle Georgiou, M.D. - 422 422 * Mika Grasso (4) - - - - David McDonald 422 422 * Gregory D. Waller - 416 416 * Robert B. Scott - - - - Nestor Jaramillo, Jr. - - - - Neil P. Ayotte - 3 3 * All current directors and executive officers as a group (7 persons) (5) 26,191 17,051 43,242 1.8% * Less than one percent. (1) Except as otherwise described below, amounts reflect the number of shares that such holder could acquire through (i) the exercise of outstanding stock options, (ii) the exercise of outstanding warrants to purchase common stock, and (iii) the conversion of outstanding Series F Preferred Stock or Series F-1 Preferred Stock, in each case within 60 days after March 24, 2026. (2) Based on 2,460,477 shares outstanding as of March 24, 2026. (3) Ms. Field joined the Board on January 21, 2026 and resigned from the Board on March 26, 2026. (4) Mr. Grasso joined the Board on January 21, 2026 and resigned from the Board on March 26, 2026. (5) The current director and exec